ProFund Advisors »

C4 Therapeutics shares owned by ProFund Advisors

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by ProFund Advisors from 13F filings

Historical chart of ProFund Advisors investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by ProFund Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.0M 126k 8.17

More positions owned by ProFund Advisors

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Qualcomm (QCOM)
Intel Corporation (INTC)
Costco Wholesale Corporation (COST)
Applied Materials (AMAT)
Netflix (NFLX)

View all positions for ProFund Advisors

Top funds holding C4 Therapeutics

State Street Corporation
RA Capital Management
Daniel D. Thurber
Lynx1 Capital Management
Commodore Capital
Vanguard Group
Soleus Capital Management
Balyasny Asset Management
T. Rowe Price Associates
Bank of America Corporation
Silverarc Capital Management
Two Sigma Advisers
Arrowpoint Asset Management
Goldman Sachs Group
TCG Crossover Management

View all funds holding C4 Therapeutics